Folgen
Twana Alkasalias
Twana Alkasalias
Bestätigte E-Mail-Adresse bei ki.se - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Fibroblasts in the tumor microenvironment: shield or spear?
T Alkasalias, L Moyano-Galceran, M Arsenian-Henriksson, K Lehti
International journal of molecular sciences 19 (5), 1532, 2018
2982018
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent
T Alkasalias, E Flaberg, V Kashuba, A Alexeyenko, T Pavlova, ...
Proceedings of the National Academy of Sciences 111 (48), 17188-17193, 2014
1132014
A zebrafish model discovers a novel mechanism of stromal fibroblast-mediated cancer metastasis
C Liu, Y Zhang, S Lim, K Hosaka, Y Yang, T Pavlova, T Alkasalias, ...
Clinical Cancer Research 23 (16), 4769-4779, 2017
882017
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
L Moyano‐Galceran, EA Pietilä, SP Turunen, S Corvigno, E Hjerpe, ...
EMBO molecular medicine 12 (4), e11177, 2020
572020
RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo
T Alkasalias, A Alexeyenko, K Hennig, F Danielsson, RJ Lebbink, ...
Proceedings of the National Academy of Sciences 114 (8), E1413-E1421, 2017
402017
Prokineticin 1 is up‐regulated by insulin in decidualizing human endometrial stromal cells
D Ujvari, I Jakson, C Oldmark, S Attarha, T Alkasalias, D Salamon, ...
Journal of Cellular and Molecular Medicine 22 (1), 163-172, 2018
342018
Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy
A Salihi, MA Al-Naqshabandi, ZO Khudhur, Z Housein, HA Hama, ...
Molecular Medicine Reports 26 (1), 233, 2022
182022
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth
A Alexeyenko, T Alkasalias, T Pavlova, L Szekely, V Kashuba, ...
Journal of Experimental & Clinical Cancer Research 34, 1-17, 2015
172015
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
T Alkasalias, J Zhang, H Madapura, B Dalarun, OB Reina, R Lewensohn, ...
Cell Death Discovery 8 (1), 464, 2022
12022
Tumor microenvironment: the paradoxical action of fibroblasts
T Alkasalias
PQDT-Global, 2018
12018
Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial
D Utjés, NR Boggavarapu, MF Rasul, I Koberg, A Zulliger, ...
International Journal of Molecular Sciences 25 (14), 7590, 2024
2024
Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
S Haran, K Chindera, M Sabry, N Wilkinson, R Arora, A Zubiak, TE Bartlett, ...
Cancers 16 (6), 1186, 2024
2024
Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage
T Mollick, S Darekar, B Dalarun, F Plastino, J Zhang, AP Fernández, ...
Heliyon 10 (1), 2024
2024
The mechanical anisotropy of adipose tissues regulates ovarian cancer invasion
J Gonzalez-Molina, P Nabili, D Marciano, S Abdelnabi, O Gultekin, ...
bioRxiv, 2024.11. 25.625153, 2024
2024
Transcriptomic profile of normal breast tissue post-mifepristone treatment: secondary outcomes of a randomized controlled trial
D Utjes, N Boggavarapu, M Rasul, I Koberg, A Zulliger, S Srinivasan, ...
medRxiv, 2024.03. 08.24303979, 2024
2024
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
S Lain, T Alkasalias, J Zhang, H Madapura, B Dalaroun, OB Reina, ...
2022
Correction: Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
T Alkasalias, J Zhang, H Madapura, B Dalarun, OB Reina, R Lewensohn, ...
Cell Death Discovery 8, 2022
2022
Abstract GMM-041: OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
L Moyano-Galceran, SP Turunen, E Pietilä, T Alkasalias, S Corvigno, ...
Clinical Cancer Research 25 (22_Supplement), GMM-041-GMM-041, 2019
2019
OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
L Moyano-Galceran, SP Turunen, E Pietila, T Alkasalias, S Corvigno, ...
CLINICAL CANCER RESEARCH 25 (22), 104-104, 2019
2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–19